| Analysis | Metabolite Name | Measured Value | Units | Tissue Type |
|---|---|---|---|---|
| ESI positive ion mode | 1-Methylhistidine | 0.000853883 | Peak area | ICC-NT (surrounded non tumor of ICC) |
| ESI positive ion mode | 1-Methylhistidine | 0.001137055 | Peak area | ICC (Intrahepatic cholangiocarcinoma) |
| ESI positive ion mode | 1-Methylhistidine | 0.001288104 | Peak area | ICC (Intrahepatic cholangiocarcinoma) |
| ESI positive ion mode | 1-Methylhistidine | 0.001364 | Peak area | ICC (Intrahepatic cholangiocarcinoma) |
| ESI positive ion mode | 1-Methylhistidine | 0.001576962 | Peak area | ICC-NT (surrounded non tumor of ICC) |
| ESI positive ion mode | 1-Methylhistidine | 0.001922152 | Peak area | ICC-NT (surrounded non tumor of ICC) |
| ESI positive ion mode | 1-Methylhistidine | 0.002993543 | Peak area | ICC (Intrahepatic cholangiocarcinoma) |
| ESI positive ion mode | 1-Methylhistidine | 0.004916539 | Peak area | ICC (Intrahepatic cholangiocarcinoma) |
| ESI positive ion mode | 1-Methylhistidine | 0.005140963 | Peak area | ICC-NT (surrounded non tumor of ICC) |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|